Impact of angiotensin inhibitors on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).

被引：0
|
作者：
Thomas, Jonathan [1 ]
Pond, Gregory Russell [2 ]
Curran, Catherine [3 ]
Freeman, Dory [3 ]
Ravi, Praful [3 ]
Mossanen, Matthew [4 ]
Preston, Mark A. [4 ]
Steele, Graeme S. [4 ]
Mantia, Charlene [3 ]
McGregor, Bradley Alexander [3 ]
Jain, Rakesh K. [5 ]
Sonpavde, Guru [3 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.432
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
432
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Impact of angiotensin-converting enzyme inhibitors (ACEi) on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
    Thomas, Jonathan
    Skelton, William Paul
    Fallah, Parvaneh
    Jain, Rohit K.
    Ravi, Praful
    Mantia, Charlene
    McGregor, Bradley Alexander
    Nuzzo, Pier Vitale
    Adib, Elio
    El Zarif, Talal
    Curran, Catherine
    Preston, Mark A.
    Clinton, Timothy Nguyen
    Li, Roger
    Steele, Graeme S.
    Kassouf, Wassim
    Freeman, Dory
    Pond, Gregory Russell
    Jain, Rakesh K.
    Sonpavde, Guru P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [2] Frequency and clinical implications of pathologic complete response (pCR) at cystectomy for muscle-invasive bladder cancer (MIBC) with or without neoadjuvant chemotherapy (NAC)
    Galsky, Matt D.
    Stensland, Kristian
    Sfakianos, John
    McBride, Russell Bailey
    Mehrazin, Reza
    Tsao, Che-Kai
    Boffetta, Paolo
    Oh, William K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [3] BLADDER-SPARING SURGERY (BSS) FOR MUSCLE-INVASIVE BLADDER CANCER (MIBC) AFTER COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NAC)
    Herr, Harry
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1084 - E1084
  • [4] Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
    Skelton Iv, William Paul
    Masur, Jack
    Thomas, Jonathan
    Fallah, Parvaneh
    Jain, Rohit K.
    Ravi, Praful
    Mantia, Charlene
    Mcgregor, Bradley Alexander
    Nuzzo, Pier Vitale
    Adib, Elio
    El Zarif, Talal
    Preston, Mark A.
    Clinton, Timothy Nguyen
    Li, Roger
    Steele, Graeme S.
    Kassouf, Wassim
    Freeman, Dory
    Pond, Gregory Russell
    Jain, Rakesh K.
    Sonpavde, Guru P.
    [J]. CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [5] Predictors of complete pathological response (pT0) to neoadjuvant chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC)
    Pokuri, Venkata Kiran
    Syed, Johar R.
    Yang, Zhengyu
    Field, Erinn P.
    Cyriac, Susanna
    Azabdaftari, Gissou
    Pili, Roberto
    Levine, Ellis Glenn
    Trump, Donald L.
    Hutson, Alan
    Guru, Khurshid
    George, Saby
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Predictors of complete pathological response (pT0) to neoadjuvant chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC)
    Pokuri, Venkata Kiran
    Syed, Johar R.
    Yang, Zhengyu
    Field, Erinn P.
    Pill, Roberto
    Levine, Ellis Glenn
    Trump, Donald L.
    Hutson, Alan
    Guru, Khurshld
    George, Saby
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] The impact of neoadjuvant chemotherapy (NAC) on conditional survival (CS) among patients with muscle-invasive bladder cancer (MIBC).
    Waingankar, Nikhil
    Jia, Rachel
    Ferket, Bart
    Audenet, Francois
    Mehrazin, Reza
    Sfakianos, John
    Mazumdar, Madhu
    Galsky, Matt D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC)
    Necchi, Andrea
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    Marandino, Laura
    Bianchi, Marco
    Gallina, Andrea
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Capitanio, Umberto
    Montorsi, Francesco
    Boormans, Joost L.
    Liu, Yang
    de Jong, Joep
    Black, Peter C.
    Dittamore, Ryan
    Davicioni, Elai
    Gibb, Ewan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] ASSOCIATION OF AN IMMUNE-GENE SIGNATURE WITH PATHOLOGIC RESPONSE AND OUTCOME AFTER NEOADJUVANT PEMBROLIZUMAB (PEMBRO), COMPARED TO NEOADJUVANT CHEMOTHERAPY (NAC), IN MUSCLE-INVASIVE BLADDER CANCER (MIBC)
    Necchi, Andrea
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    Marandino, Laura
    Gallina, Andrea
    Bianchi, Marco
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Capitanio, Umberto
    Montorsi, Francesco
    Boormans, Joost
    Liu, Yang
    de Jong, Joep
    Dittamore, Ryan
    Davicioni, Elai
    Black, Peter
    Gibb, Ewan
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E841 - E841
  • [10] Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Miyagi, Hiroko
    Kwenda, Elizabeth
    Ramnaraign, Brian H.
    Chatzkel, Jonathan A.
    Brisbane, Wayne G.
    O'Malley, Padraic
    Crispen, Paul L.
    [J]. CANCERS, 2023, 15 (01)
12345